Recall Z-1474-2026— Remel, Inc

Class II · Ongoing

Class II FDA medical device recall by Remel, Inc, initiated 2026-02-05. FDA's recall record names no specific 510(k) clearance for this event. Product: Campy CVA Medium 100/PK, R01272. Reason: Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium..

Recalling firm
Remel, Inc
Classification
Class II
Status
Ongoing
Initiated
2026-02-05
Firm location
Lenexa, KS, United States

Product description

Campy CVA Medium 100/PK, R01272

Reason for recall

Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

Data sourced from openFDA. This site is unofficial and independent of the FDA.